Inventor · disambiguated record
Ulrich Lücking
Also filed as: LUCKING ULRICH · LUECKING ULRICH · Lücking Ulrich
38 granted patents·13 pending applications·252 citations·filing 2002–2022
97Inventor score
Top patents by PatentIndex Score
51 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0294US7288547B2CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Oct 30, 2007·54 cites·24 claims
- 0393US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 0492US7235561B2Compound and a composition including such a compoundSCHERING AG·Filed 2002·Granted Jun 26, 2007·58 cites·58 claims
- 0589US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 0689US7598260B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 6, 2009·13 cites·79 claims
- 0788US7750000B2Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicamentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Jul 6, 2010·24 cites·2 claims
- 0885US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 0985US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
- 1083US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 1182US7291624B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Nov 6, 2007·16 cites·90 claims
- 1281US8735412B2Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicineLücking Ulrich·Filed 2009·Granted May 27, 2014·6 cites·19 claims
- 1381US7825128B2Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugsBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 2, 2010·7 cites·18 claims
- 1479US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 1578US10214542B2Modified macrocyclic compoundsBayer Pharma AG·Filed 2016·Granted Feb 26, 2019·2 cites·27 claims
- 1678US8802686B2Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicineLücking Ulrich·Filed 2009·Granted Aug 12, 2014·4 cites·12 claims
- 1777US10717749B2Macrocyclic sulfondiimine compoundsBayer Pharma AG·Filed 2016·Granted Jul 21, 2020·2 cites·17 claims
- 1875US11254690B2PTEFb inhibiting macrocyclic compoundsBAYER AG·Filed 2018·Granted Feb 22, 2022·1 cites·22 claims
- 1975US11242356B2PTEFb inhibiting macrocyclic compoundsBAYER AG·Filed 2018·Granted Feb 8, 2022·1 cites·22 claims
- 2075US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 2173US9963464B2Macrocyclic compoundsBayer Pharma AG·Filed 2015·Granted May 8, 2018·2 cites·29 claims
- 2273US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 2370US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 2469US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 2567US11691986B2PTEFB inhibiting macrocyclic compoundsBAYER AG·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 2667US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 2766US9790189B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine groupBayer Pharma AG·Filed 2015·Granted Oct 17, 2017·1 cites·26 claims
- 2865US2022281892A1Novel ptefb inhibiting macrocyclic compoundsBAYER AG·Filed 2022·Application pending·0 cites
- 2962US8507510B2Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agentsLUECKING ULRICH·Filed 2004·Granted Aug 13, 2013·3 cites·20 claims
- 3057US9770445B2Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Sep 26, 2017·0 cites·12 claims
- 3154US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 3248US9962389B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupBAYER IP GMBH·Filed 2017·Granted May 8, 2018·0 cites·15 claims
- 3348US8003787B2Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 23, 2011·0 cites·21 claims
- 3448US2009005373A1Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2007·Application pending·0 cites
- 3546US2015259300A14-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone groupBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3645US9670161B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jun 6, 2017·0 cites·5 claims
- 3744US9708293B2N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·0 cites·12 claims
- 3844US9586958B2Prodrug derivatives of substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Mar 7, 2017·0 cites·14 claims
- 3944US2016207928A1Novel compounds for the treatment of cancerBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4042US9856242B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2015·Granted Jan 2, 2018·0 cites·15 claims
- 4142US2007191393A1Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinasesLUCKING ULRICH·Filed 2007·Application pending·0 cites
- 4242US2006111378A1Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agentsCLEVE ARWED·Filed 2005·Application pending·0 cites
- 4342US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4437US9902716B2Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone groupBayer Pharma AG·Filed 2015·Granted Feb 27, 2018·0 cites·22 claims
- 4536US9884849B2Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2015·Granted Feb 6, 2018·0 cites·23 claims
- 4636US9650361B2N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine groupBAYER PHARAM AG·Filed 2013·Granted May 16, 2017·0 cites·15 claims
- 4736US2013079345A1Pharmaceutically active disubstituted triazine derivativesEICKHOFF JAN·Filed 2011·Application pending·0 cites
- 4836US2017342064A1Compounds for the treatment of cancerBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4932US2013210846A1Use of novel pan-cdk inhibitors for treating tumorsLUECKING ULRICH·Filed 2011·Application pending·0 cites
- 5032US2012238533A1(Heteroarylmethyl) Thiohydantoins as anticancer drugsCLEVE ARWED·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →